Role of Doppler Ultrasound in Severe Peptic Ulcer Hemorrhage
Study Details
Study Description
Brief Summary
The aim of study is to evaluate whether Doppler ultrasound can accurately identify patients who are at risk of recurrent bleeding, who will require endoscopic therapy, and who will fail endoscopic therapy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Bleeding peptic ulcer is a life-threatening emergency. Endoscopic therapy is a proven technique in the acute hemostasis of bleeding ulcers. Currently there is no objective assessment of adequacy of endoscopic therapy. Endoscopic Doppler ultrasound enables endoscopists in detecting blood flow in a vessel beneath an ulcer. A persistent signal after endoscopic therapy predicts recurrent bleeding. The current study proposes to compare assessment of ulcer base using either Doppler ultrasound or endoscopists' interpretation of ulcer floors. The trial design is one of a prospective randomized controlled cross-over study in which patients with severe upper gastrointestinal bleeding and documented peptic ulcers at endoscopy are enrolled.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Doppler ultrasound
|
Device: Doppler ultrasound probe
Applying to ulcer base to assess the blood flow underneath the ulcer
Other Names:
|
No Intervention: No Doppler ultrasound
|
Outcome Measures
Primary Outcome Measures
- Recurrent bleeding [Within 30 days]
Secondary Outcome Measures
- Length of stay [Within 56 days]
- ICU utilization [Within 56 days]
- Blood Transfusion during hospital [Within 56 days]
- Need for urgent/emergent ulcer surgery for bleeding [Within 56 days]
- Need for angiographic treatment of bleeding [Within 56 days]
- Death [within 56 days]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Clean base ulcer with severe upper GIB (defined as melaena, hematochezia, hematemesis, and/or gross blood in NG lavage), and any one of the following:
-
SBP ≤ 90mmHg; P of ≥110 bpm; or orthostatic changes with SBP drops 20mmHg or P increases 20 bpm; or,
-
Transfusion of 2 or more units of packed red blood cells within 12 hrs of admission; or,
-
A documented HCT drop of at lest 6% from baseline.
-
Endoscopically confirmed bleeding from GU, DU, pyloric ulcer, or anastomotic ulcer
-
Pt can either have primary or secondary acute UGI haemorrhage
Exclusion Criteria:
-
Bleeding site from lesion other than GU, DU, pyloric or anastomotic ulcer
-
there is more than one type of significant bleeding lesion
-
Documented hx of cirrhosis / portal HT
-
ESRF requiring any form of dialysis
-
Expected or persistent (>24hrs) coagulopathy with INR> 1.5
-
Platelet count is under 50000/mm3
-
Aspirin User / Plavix [Clopidogrel] User
-
If the ulcer is neoplastic
-
Cannot obtained consent
-
Age < 18 or is pregnant
-
Severe comorbid of which life expectancy <30 days
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Endoscopy Center, Prince of Wales Hospital | Hong Kong SAR | China |
Sponsors and Collaborators
- Chinese University of Hong Kong
- University Hospitals Cleveland Medical Center
Investigators
- Principal Investigator: James Y Lau, MD, Prince of Wales Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- DOP-US study